Cargando…
Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy
PURPOSE/OBJECTIVE(S): To determine, for intact melanoma brain metastases (MBM) treated with single-fraction stereotactic radiosurgery (SRS), whether planning parameter peripheral dose per lesion diameter (PDLDm, Gy/mm) and lesion control (LC) differs with versus without immunotherapy (IO). MATERIALS...
Autores principales: | Yusuf, Mehran, Rattani, Abbas, Gaskins, Jeremy, Oliver, Alexandria L., Mandish, Steven F., Burton, Eric, May, Michael E., Williams, Brian, Ding, Dale, Sharma, Mayur, Miller, Donald, Woo, Shiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606626/ https://www.ncbi.nlm.nih.gov/pubmed/34807342 http://dx.doi.org/10.1007/s11060-021-03899-0 |
Ejemplares similares
-
Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents
por: Acharya, Sahaja, et al.
Publicado: (2017) -
Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
por: Liermann, Jakob, et al.
Publicado: (2020) -
Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases
por: Nguyen, Steven M, et al.
Publicado: (2017) -
Stereotactic radiosurgery for brain metastases from malignant melanoma
por: Christ, Sebastian M., et al.
Publicado: (2015) -
Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases
por: Yoo, Kelly H., et al.
Publicado: (2023)